ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SMMT Summit Therapeutics Inc

4.39
0.33 (8.13%)
After Hours
Last Updated: 07:59:08
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Summit Therapeutics Inc SMMT NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.33 8.13% 4.39 07:59:08
Open Price Low Price High Price Close Price Previous Close
4.08 4.06 4.50 4.39 4.06
more quote information »

Recent News

Date Time Source Heading
01/5/202421:00BWSummit Therapeutics Reports Financial Results and..
25/4/202406:30BWSummit Therapeutics to Host First Quarter 2024 Financial..
12/4/202406:30BWSummit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned..
10/4/202421:00BWSummit Therapeutics to Present at the Stifel 2024 Targeted..
22/3/202422:00BWPromising Intracranial Anti-Tumor Activity and Safety Data..
14/3/202422:00BWIntracranial Anti-Tumor Activity and Safety of Ivonescimab..
06/3/202408:05EDGAR2Form 8-K - Current report
05/3/202423:00BWSummit Therapeutics to Present at the Barclays 26th Annual..
21/2/202400:05EDGAR2Form 8-K - Current report
20/2/202423:55EDGAR2Form S-3 - Registration statement under Securities Act of..
20/2/202423:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202423:00BWSummit Therapeutics Reports Financial Results and..
16/2/202409:25EDGAR2Form 8-K - Current report
15/2/202408:35EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
15/2/202402:29BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023..
14/2/202423:00BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023
07/2/202423:00BWSummit Therapeutics to Present at Oppenheimer’s 34th Annual..
09/1/202401:07EDGAR2Form 8-K - Current report
09/1/202401:00BWSummit Therapeutics Announces Updated Phase II Data for..
05/1/202408:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:06EDGAR2Form 8-K - Current report
03/1/202423:30BWSummit Therapeutics to Present at the 42nd Annual J.P...
14/12/202308:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202300:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202300:03EDGAR2Form 8-K - Current report
07/11/202323:00BWSummit Therapeutics Reports Financial Results and..
03/11/202307:41BWLaura Chow, MD, Cancer Immunotherapy Trailblazer, Joins..
01/11/202307:02EDGAR2Form 8-K - Current report
31/10/202323:00BWIvonescimab’s Novel Mechanism of Action Highlighting..
26/10/202323:00BWSummit Therapeutics to Host Q3 2023 Financial Results &..
19/10/202323:00BWH. Jack West, MD, Renowned Oncologist & Lung Cancer Expert,..
16/10/202322:46EDGAR2Form 8-K - Current report
16/10/202322:00BWSummit Therapeutics Appoints Proven Biotech Leader Manmeet..
20/9/202305:40EDGAR2Form DEF 14A - Other definitive proxy statements
09/9/202306:08EDGAR2Form PRE 14A - Other preliminary proxy statements
10/8/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:03EDGAR2Form 8-K - Current report
09/8/202321:00BWSummit Therapeutics Reports Financial Results and..
03/8/202306:05EDGAR2Form 8-K - Current report
02/8/202322:00BWSummit Therapeutics to Host Q2 2023 Financial Results &..
04/6/202322:00BWPromising Data for Investigational Innovative Bispecific..
01/6/202321:30BWIvonescimab Updated Data to be Featured at ASCO 2023
11/5/202321:30BWSummit Therapeutics Reports Financial Results and..
09/5/202321:30BWSummit Therapeutics Announces First Patient Treated in Phase..

Your Recent History

Delayed Upgrade Clock